The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Having done my own research, I think you could regret that trade. Not that I have a problem with HELD as KNB have a holding there, but this company has not even begun to realise its potential and with the news just in from Germany I will be holding long here. GL with HELD.
Just taken some profit here and added to the above.
When the market catches on, HELD will be the next big mover in this sector.
As always, DYOR.
Really good to see the company have acknowledged this milestone news from Germany that adds confidence to their own business forecast . Stocks rising in the US with more anticipated good news to come with the DEA rescheduling of cannabis and if passed then im sure the UK will get on board probably a lot sooner than expected
Let’s hope the uk follows suit now
I agree, it’s been a bit quiet and SP didn’t have anything to go off, whilst this RNS doesn’t give us anything substantial at this stage it does show that there is movement. Share price has had a small positive move though which is encouraging. Hopefully the full year results along with news on the CE certificate will get this SP moving north
Very encouraging RNS and the progress made with a long term outlook about the position of the group as one of long term players and the advantages to support that. Hopefully more good news to follow
Let's see what's in the Chancellor's budget on Wednesday hopefully some good news for the medical cannabis sector and a revenue boost to the economy.
Not in the control of KNB when CE mark is issued but I think we would know if it was a fail. Meanwhile Germany set to legalise weed on april 1st, so lets hope we have it by then as they are a big target market for the vape pod.
https://www.forbes.com/sites/dariosabaghi/2024/02/05/germanys-government-coalition-reaches-final-deal-on-cannabis-legalization/?sh=2a3855e96f6f
I feel the lack of news here is a bit disappointing. Anticipating CE approval was Q4 23 and here we are half way through Q1 24 without an update. I hope it’s not far away.
If the uk Gov does not get its act together there a risk of a supply/demand issue further down the road as the demand and awareness increases. Other countries are already upping their game and signing pre orders with the cultivators whilst some UK cultivators are contracted to ship abroad as the sector begins to hot up.
I was reading this to and found it quite a positive interesting read
Trawling through news articles, came
across this last year from a wealth management consultant making an investment in Kanabo, fairly
sizeable investment :
Mattioli invests in medicinal cannabis group, £500k.
Some positive sentiment in the company!
A very encouraging read
https://www.theguardian.com/society/2024/feb/11/wonder-drug-is-the-uk-ready-for-the-green-rush-of-medicinal-cannabis
I have a buy order @1.60 on since weds, only a small punt, but couldn’t get any since
The medical cannabis sector is still in its infancy and I think the German legalisation and the US DEA rescheduling will be a big boost to the industry and we could see the start of it in the coming months. As with the share price yes it looks like its doing the full circle back to the lows of last year but those vast amount of small trades could be algorithm tricks that split up big trades whether buys or sells and keeping retail investors in limbo as to where the real value is
The drop mirrors the drop we had 12 months ago, nice rise on potential good news then a decline back to pre boost levels, can’t seem to get anything to hold this stock up. Business results should hopefully show revenue improvements which will help, there is a risk that the business need more capital to grow which could weaken the share price even further in the short term but if that capital request was off the back of the patented certificate being signed off then I think we’ve got a clear view forward. Not heard anything from Ian Mattoli since investing and joining the board.
The report from last weeks cannabis invest conference has produced optimism and highlighted the challenges on where the Medical Cannabis industry is in the UK including an input from Kanabo CEO Avihu Tamir. Maybe the reason the price has continued to fall but giving more unexpected buying opportunities at these lower levels .Lets see if a business update is released soon with signs that alls going well.
https://businessofcannabis.com/the-turning-point-is-happening-insights-from-the-6th-annual-cannabis-invest-uk-conference/.
About time they banned disposable vapes, a rare act of responsibility on behalf of our half baked govt, and the 24292 reported sell is in fact a buy.
KNB investor presentation on wed Jan 31st, check Avihu Tamir on Linkedin.
Agree with that, that was a case of scaremongering if I didn’t see one.
I actually see this as a good thing, the single use vape market doesn’t have a great reputation and this could be creating a negative opinion on the idea of vales in general, especially with an older demographic (Kanabo target group)
single use out the way might improve confidence with reusable/ cartridge ones.
This is single use vapes not medicinal or prescription
Https://news.sky.com/story/disposable-vapes-to-be-banned-over-concerns-of-sharp-increase-in-childrens-use-13058596
Sorry for holderrs here
Looks to be a disaster
Times they are a changing.
https://cannabishealthnews.co.uk/2024/01/16/us-health-officials-acknowledge-accepted-medical-use-of-cannabis/
Interesting development this morning.
Whilst we await imminent approval of our CE marked measured dose Vape and also, the potential to be involved in the tender for the NHS telemedicine contract, a little ‘side hussle’ is announced, the start of a whole new ‘walk in pain management’ business, using an existing pharmacy.
Interesting that our network of pharmacies has grown to nearly 6000 following the acquisition of the GP Service a few years ago.
Had great difficulty averaging down today. Only way I could get in was via a Tradeplan. I've maxed it at 2.40 so hopefully I'll get in soon. I still think this stock has some legs.